Gamma-hydroxybutyrate - an endogen substance with abuse potential;Gammahydroksybutyrat - endogen substans og rusmiddel

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 28, 1998, Pages 4390-4393

  Hovda, Knut Erik ^a   Liberg, John Petter ^a   Nordby, Gudmund ^a   Jacobsen, Dag ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; OXYBATE SODIUM;

ADDICTION; ADULT; ARTICLE; CASE REPORT; CHEMISTRY; HUMAN; MALE; PATHOPHYSIOLOGY;

ADULT; HUMANS; MALE; NEUROTRANSMITTER AGENTS; SODIUM OXYBATE; SUBSTANCE-RELATED DISORDERS;

EID: 0032553168     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R et al. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 1993; 45: 353-6.
2. Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986; 9: 285-9.
3. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 1989; 1: 787-9.
4. Colombo G, Agabio R, Lobina C. Reali R, Fadda F, Gessa GL. Cross-tolerance to ethanol and γ-hydroxybutyric acid. Eur J Pharmacol 1995; 273: 235-8.
5. Myrcnfors P. Tio förgiftningar med gamma-hydroxibutyrat. Läkartidningcn 1996; 93: 1973-4.
6. Geldenhuys KG, Sonncndecker EWW, De Klerk MCC. Experience with sodium-gamma-4-hydroxybutyric acid in obstetrics. J Obstct Gynaecol Br Commonw 1968; 75: 405-13.
7. Louagie HK, Verstraete AG, De Soete CJ, Baetens DG, Calle PA. A sudden awakening from a near coma after combined intake of gamrna-hydroxybutyric acid (GHB) and ethanol. Clin Toxicol 1997; 36: 591-4.
8. Takahara J. Yunoki S, Yakushiji W, Yamauchi J, Yamane Y, Ofuji T. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 1977; 44: 1014-7.
9. Thomas G, Bonner S. Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GHB or liquid ecstacy): a casereport. BMJ 1997; 3:35-6.
10. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB) - a neuroactive drug with abuse potential. Clin Toxicol 1997; 35: 581-90.
11. Bessman SP, Fishbein WM. Gamma-hydroxybutyrate, a normal brain metabolite. Nature 1963; 200: 1207-8.
12. Snead OC, Morley BJ. Ontogeny of γ-hydroxy-butyric acid. I. Regional concentration in developing rat, monkey and human brain. Brain Res 1981; 227: 579-89.
13. Vayer P, Ehrhardt J-D, Gobaille S, Mandel P, Maitre M. Gamma-hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat. Neurochem Int 1988; 12: 53-9.
14. Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SE, Smith DE. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92: 89-96.
15. Gessa G, Vargiu L, Crabai F, Boero G, Caboni F, Camba R. Selective increase of brain dopamine induced by gamma-hydroxy-butyrate. Life Sciences 1966; 5: 1921-30.
16. Friedman J, Westlake R, Furman M. «Grievous bodily harm»: gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology 1996; 46: 469-71.
17. Roth R, Doherty J, Walters J. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Res 1980; 189: 556-60.
18. Cheramy A, Nieoullon A, Glowinsky J. Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. J Pharmacol Exp Ther 1977; 203: 283-93.
19. Godbout R, Jelenic P, Labrie C, Schmitt M, Bourguignon J-J. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res 1995; 673: 157-60.
20. Hechler V, Gobaille S, Bourguignon J-J, Maitre M. Extracellular events induced by γ-hydroxybutyrate in striatum: a microdialysis study. J Neurochem 1991; 56: 938-44.
21. Howard SO, Feigenbaum JJ. Effect of γ-hydroxybutyrate on central dopaminerelease in vivo. Biochem Pharmacol 1997; 53: 103-10.
22. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa G. Low doses of γ-hydroxybutyric acid stimulate the firing fate of dopaminergic neurons in unanesthetized rats. Brain Res 1991; 566: 208-11.
23. Cash CD. Gamma hydroxybutyrate: an overview of the pros and cons for it being a neuro-transmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994; 18: 291-304.
24. Vickers M. Gammahydroxybutyric acid. Int Anesth Clin 1969; 7: 75-89.
25. Dyer JE. γ-hydroxybutyrate: a health-food product producing coma and seizure-like activity. Am J Emerg Med 1991; 9: 321-4.
26. Helrich M, McAslan TC, Skolnik S, Bessman SP. Correlation of blood levels of 4-hydroxybutyrate with state of consciousness. Anesthesiology 1964; 25: 771-5.
27. Hoes MJ, Vree TB, Guelen PJ. Gamma-hydroxybutyric acid as hypnotic. Encephale 1980; 6: 93-9.
28. Series F, Series I, Cormier Y. Effects of enhancing slow-wave sleep by gammahydroxybutyrate on obstructive sleep apnea. Am Rev Respir Dis 1992; 145: 1378-83.
29. Scrima L. Gamma-hydroxybutyrate (GHB) treated narcolepsy patients continue to report cataplexy controlled for up to five (5) years. Sleep Research 1992; 21: 262.
30. Scrima L, Hartman PG, Johnson FJ, Thomas EE, Killer FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double blind study. Sleep 1990; 13: 479-90.
31. Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep 1993; 16: 216-20.
32. Gerra G, Marcato A, Affini GF, Avanzini P, Lecchini R, Maestri D et al. Gamma-hydroxybutyric acid (GHB) and neuroendocrine function in humans. Neuroendocrinol Lett 1994; 16: 55-63.
33. Stell JM, Ryan JM. Gamma-hydroxybutyrate is a new recreational drug that might lead to loss of consciousness. BMJ 1996; 313: 424.
34. Galloway GP, Frederick SL, Staggers F. Physical dependence on sodium oxybate. Lancet 1994; 343: 57.
35. McCabe E, Layne E, Sayler D, Slusher N. Synergy of ethanol and a natural soporific-gamma hydroxybutyrate. Science 1971; 171: 404-6.
36. Centers for Disease Control. Multistate outbreak of poisonings associated with illicit use of gamma-hydroxybutyrate. JAMA 1991; 265: 447-8.
37. Chin MY, Kreutzer RA, Dyer JE. Acute poisoning from gamma-hydroxybutyrate in California. West J Med 1992; 156: 380-4.
38. Metcalf DR, Emde RN, Stripe JT. An EEG-behavioral study of sodium hydroxybutyrate in humans. Electroencephalogr Clin Neurophysiol 1966; 20: 506-12.
39. Gamma hydroxy butyrate use - New York and Texas, 1995-1996. MMWR - Morb Mortal Wkly Rep 1997; 46: 13.
40. Ferrara SD, Tedeschi L, Frison G, Rossi A. Fatality due to garnma-hydroxybutyric acid (GHB) and heroin intoxication. J Forensic Sci 1995; 40: 501-4.
41. Feigenbaum JJ, Howard SG. Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study. Neurosci Lett 1996; 218: 5-8.